Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 10666232

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2000 Feb 15
First author
Kuehnle I

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kuehnle I
      type
      Author
    2. name
      Huls MH
      type
      Author
    3. name
      Liu Z
      type
      Author
    4. name
      Semmelmann M
      type
      Author
    5. name
      Krance RA
      type
      Author
    6. name
      Brenner MK
      type
      Author
    7. name
      Rooney CM
      type
      Author
    8. name
      Heslop HE
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kuehnle I
      type
      Author
    2. name
      Huls MH
      type
      Author
    3. name
      Liu Z
      type
      Author
    4. name
      Semmelmann M
      type
      Author
    5. name
      Krance RA
      type
      Author
    6. name
      Brenner MK
      type
      Author
    7. name
      Rooney CM
      type
      Author
    8. name
      Heslop HE
      type
      Author
    bibliography ids
    1. nci-bib-de8362e5910c3e3ff4d19417
    book metadata
    content sha256
    7bf1f02717ee02aebd5cfc9aef466a64c36d9cc57a83f7927c376679795013c0
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:10666232
      immutable id
      pubmed:10666232@7bf1f02717ee02aebd5cfc9aef466a64c36d9cc57a83f7927c376679795013c0
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      4
      name
      Blood
      nlm unique id
      7603509
      pages
      1502-5
      volume
      95
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        10666232
        provenance
        batch id
        40703d4bdd5a70d2c67a
        provider
        NCBI PubMed ESummary
        record sha256
        c07857b6b9ab55a5dc74f2accf103f622064f2042ac8aff5633ea27fe2f391d0
        response sha256
        a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
        retrieved at
        2026-09-09T23:45:35.800055+00:00
        publication date
        display
        2000 Feb 15
        precision
        day
        year
        2000
        publication types
        1. Case Reports
        2. Journal Article
        3. Research Support, U.S. Gov't, P.H.S.
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/10666232/
        title
        CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

        Preserved source evidence · Independent clinical review pending · Not medical advice